DK0643973T3 - Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi - Google Patents

Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi

Info

Publication number
DK0643973T3
DK0643973T3 DK94112221T DK94112221T DK0643973T3 DK 0643973 T3 DK0643973 T3 DK 0643973T3 DK 94112221 T DK94112221 T DK 94112221T DK 94112221 T DK94112221 T DK 94112221T DK 0643973 T3 DK0643973 T3 DK 0643973T3
Authority
DK
Denmark
Prior art keywords
preparation
myeloid leukemia
treatment
chronic myeloid
human interferon
Prior art date
Application number
DK94112221T
Other languages
English (en)
Inventor
Rita Michalevicz
Original Assignee
Univ Ramot
Interpharm Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot, Interpharm Lab Ltd filed Critical Univ Ramot
Application granted granted Critical
Publication of DK0643973T3 publication Critical patent/DK0643973T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK94112221T 1989-03-19 1990-03-15 Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi DK0643973T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL89662A IL89662A (en) 1989-03-19 1989-03-19 Pharmaceutical compositions comprising interferon-beta

Publications (1)

Publication Number Publication Date
DK0643973T3 true DK0643973T3 (da) 2003-09-08

Family

ID=11059803

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90104936.1T DK0388799T3 (da) 1989-03-19 1990-03-15 Anvendelse af human beta-interferon til stimulering af erythropoiesis
DK94112221T DK0643973T3 (da) 1989-03-19 1990-03-15 Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK90104936.1T DK0388799T3 (da) 1989-03-19 1990-03-15 Anvendelse af human beta-interferon til stimulering af erythropoiesis

Country Status (12)

Country Link
US (1) US5104653A (da)
EP (2) EP0643973B1 (da)
JP (1) JP2883669B2 (da)
AT (2) ATE240116T1 (da)
AU (1) AU619960B2 (da)
CA (1) CA2011992C (da)
DE (2) DE69031355T2 (da)
DK (2) DK0388799T3 (da)
ES (2) ES2198409T3 (da)
GR (1) GR3024763T3 (da)
IL (1) IL89662A (da)
ZA (1) ZA901994B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
JP4066460B2 (ja) * 1995-07-25 2008-03-26 東レ株式会社 骨疾患治療薬
US6239109B1 (en) 1998-02-09 2001-05-29 University Of Southern California Method of promoting erythropoiesis
HU228583B1 (en) * 2000-11-07 2013-04-29 Novartis Vaccines & Diagnostic Stabilized interferon compositions
WO2002040646A1 (en) * 2000-11-14 2002-05-23 Universite Libre De Bruxelles Generation and use of dendritic cells
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US8084424B2 (en) * 2003-04-09 2011-12-27 University Of Utah Research Foundation Compositions and methods related to erythropoietin
GB2429207A (en) 2004-02-02 2007-02-21 Ambrx Inc Modified human interferon polypeptides and their uses
AU2005239995A1 (en) * 2004-03-31 2005-11-17 Nitromed, Inc. Methods for treating blood disorders with nitric oxide donor compounds
EP1984010A4 (en) * 2006-02-17 2010-09-08 Nitromed Inc METHOD FOR USE OF HYDRALAZIN COMPOUNDS AND ISOSORBIDE DINITRATE OR ISOSORBIDE MONONITRATE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders

Also Published As

Publication number Publication date
CA2011992C (en) 2003-04-29
US5104653A (en) 1992-04-14
EP0643973A1 (en) 1995-03-22
IL89662A0 (en) 1989-09-28
JPH0314523A (ja) 1991-01-23
IL89662A (en) 1997-11-20
EP0388799B1 (en) 1997-09-03
DE69031355D1 (de) 1997-10-09
EP0643973B1 (en) 2003-05-14
ZA901994B (en) 1990-12-28
AU619960B2 (en) 1992-02-06
GR3024763T3 (en) 1997-12-31
CA2011992A1 (en) 1990-09-19
ATE240116T1 (de) 2003-05-15
DE69034076T2 (de) 2003-11-20
ES2198409T3 (es) 2004-02-01
ATE157544T1 (de) 1997-09-15
DE69031355T2 (de) 1998-01-08
DK0388799T3 (da) 1998-03-30
DE69034076D1 (de) 2003-06-18
AU5144590A (en) 1990-09-20
EP0388799A3 (en) 1991-07-31
JP2883669B2 (ja) 1999-04-19
ES2107414T3 (es) 1997-12-01
EP0388799A2 (en) 1990-09-26

Similar Documents

Publication Publication Date Title
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
NZ216172A (en) Nucleosides and pharmaceutical compositions
DK0392300T3 (da) Anvendelse af lægemidler, der indeholder mindst et cytokin, til systemisk behandling af præneoplastiske læsioner
DK0643973T3 (da) Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
DK0500773T3 (da) Ikke-glycosyleret FGF-4 og præparater indeholdende dette
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
DK0553294T3 (da) Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DE68900760D1 (de) Virushemmende nukleosidmischung.
DK0452598T3 (da) Anvendelsen af et polypeptid med humant-inter-leukin-2-aktivitet til fremstilling af farmaceutiske præparater til behandling af primitiv pleuracancer
DK328088D0 (da) Farmaceutisk komposition til behandling af tumorer
DK350286D0 (da) Praeparat til parenteral indgivelse af et peptid over et laengere tidsrum, dets fremstilling og anvendelse
IE871358L (en) Interferon for carcinoma
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
IL84080A0 (en) Human leukocyte interferon compositions for skin treatment
EP0491873A4 (en) Therapeutic compositions; methods for treatment of hiv infections
IT8720034A0 (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
IL84550A (en) Pharmaceutical compositions for treatment of viral infections containing 3( -fluoro-3(-deoxy-thymidine
KR920014480A (ko) 기흉 치료용 제약 조성물을 제조하기 위한 인간 인터류킨 2의 활성을 갖는 폴리펩티드의 용도
IT8048117A0 (it) Composizione per il trattamento di infezioni virali e procedimento di preparazione
JPS5731618A (en) Drug composition having antitumor action